about
Lung transplantation at DukeClinical predictors and outcome implications of early readmission in lung transplant recipientsThe utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates.Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.Extracorporeal Membrane Oxygenation and Interfacility Transfer: A Regional Referral Experience.Extracorporeal membrane oxygenation following lung transplantation: indications and survival.Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival.Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients.A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry.Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma.A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer.Transplant size mismatch in restrictive lung disease.Fatal SV40-associated pneumonia and nephropathy following renal allotransplantation in rhesus macaque.Getting to transplantation.Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study.The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation.Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.The President's gallbladder: a historical account of the cholecystectomy of Lyndon Baines Johnson.Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantationSecondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study
P50
Q26748519-99F2593A-0499-4C07-88F4-1EE603E9A282Q33866164-02C5D93A-6206-4AFF-BDAF-54FB2829C1DBQ33866177-EC68E19D-1170-48D3-B12F-05ABAB6D3B30Q34369398-F2F2F8D8-611E-4BD1-B4A4-0C377E237D01Q38369970-B3CE774A-0029-4997-91FD-89A5F7749B06Q38676831-3EA390BC-28E0-4DFC-BC97-638C960B6BD0Q38698950-B8DA078E-2D81-4DDF-9775-B150E18D1B90Q38805494-95CE3521-E337-4164-8E57-D2C990358816Q38810467-2A6AAC91-69DE-4B3F-A34C-79BFB52AF0DFQ38906723-3419DD80-AB4F-4C07-9CC7-E8BBD64E9CFEQ39152748-0315FA00-859B-4319-96AD-827206AA1887Q41711876-25D8FF8C-957D-4B48-864F-6BB5753AACCBQ44745521-DCCB205B-BA1F-4874-9499-7CEAFB20D72AQ45994560-C7F8848B-E75E-4EE5-9FDF-D3B8F90707C5Q47245500-FA82C134-B294-47AE-9056-CBF5966270F5Q47722423-0AF013D3-C038-44F6-8D14-D3097D318A98Q48146714-8B330115-8B3A-428F-98D9-F1A4FE2B4F38Q48191406-95C32A94-F77E-48D9-9494-F1B92CAA925DQ48194253-C5A2D8B8-DFC3-48A3-A2F1-AECEB6CC8EFDQ48207019-C600AA34-9FF6-41BC-B5F8-381B4B37188FQ48472528-D7A2885B-81BE-463C-B36C-B6AA82DD8456Q50652203-B1500CAB-D707-45C4-8EC8-92EB841A42FBQ50659097-D3CED427-78DA-413A-A591-41E4522061E7Q90881437-FE14BFC6-31F0-481B-BB7C-1DF9B0C28CDDQ92495746-38A055D9-7932-425A-B06D-F86886044FD4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael S. Mulvihill
@ast
Michael S. Mulvihill
@en
Michael S. Mulvihill
@es
Michael S. Mulvihill
@nl
Michael S. Mulvihill
@sl
type
label
Michael S. Mulvihill
@ast
Michael S. Mulvihill
@en
Michael S. Mulvihill
@es
Michael S. Mulvihill
@nl
Michael S. Mulvihill
@sl
prefLabel
Michael S. Mulvihill
@ast
Michael S. Mulvihill
@en
Michael S. Mulvihill
@es
Michael S. Mulvihill
@nl
Michael S. Mulvihill
@sl
P106
P108
P1153
55262112600
P21
P31
P3835
michael-mulvihill
P496
0000-0002-8122-1483